PCNA and infectious otitis media: Silibinin decreased proliferating cell nuclear antigen (PCNA) and cyclin D1 expression and increased cyclin-dependent kinase-interacting protein 1 (Cip1)/p21 expression in A/J mice administered with AOM, which indicates its antiproliferative and proapoptotic effect [53].